Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tyra Biosciences, Inc. | Director | Common Stock (Right to Buy) | 37.2K | $464K | $12.48 | May 7, 2024 | Direct |
BioAtla, Inc. | Director | Common Stock | 28.8K | $43.5K | $1.51 | Jun 13, 2024 | Direct |
RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 0 | $0 | $62.50 | Feb 26, 2024 | Direct |
BioAtla, Inc. | Director | Stock Option (Right to Buy) | 50K | Jun 14, 2023 | Direct | ||
RayzeBio, Inc. | CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 0 | Feb 26, 2024 | Direct | ||
Tyra Biosciences, Inc. | Director | No securities are beneficially owned. | 0 | May 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCAB | BioAtla, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
TYRA | Tyra Biosciences, Inc. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
TYRA | Tyra Biosciences, Inc. | May 7, 2024 | 0 | $0 | 3 | May 9, 2024 | Director |
RYZB | RayzeBio, Inc. | Feb 26, 2024 | 5 | -$20.2M | 4 | Feb 27, 2024 | CHIEF MEDICAL OFFICER |
RYZB | RayzeBio, Inc. | Jan 22, 2024 | 2 | $100K | 4 | Feb 6, 2024 | CHIEF MEDICAL OFFICER |
RYZB | RayzeBio, Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 17, 2023 | Chief Medical Officer |
RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Chief Medical Officer |
BCAB | BioAtla, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
BCAB | BioAtla, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
BCAB | BioAtla, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |